Literature DB >> 15721020

Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease.

Tetsuro Miyazaki1, Kazunori Shimada, Osamu Sato, Kazuo Kotani, Atsumi Kume, Katsuhiko Sumiyoshi, Yayoi Sato, Hirotoshi Ohmura, Yoshiro Watanabe, Hiroshi Mokuno, Hiroyuki Daida.   

Abstract

OBJECTIVE: Recent studies have suggested that circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) is a useful marker for the identification of patients with coronary artery disease (CAD). However, the role of MDA-LDL in atherogenic mechanisms has not yet been fully determined. METHOD AND
RESULTS: We investigated lipoprotein profiles measured by nuclear magnetic resonance (NMR) spectroscopy and circulating MDA-LDL levels measured by ELISA in 25 male patients with CAD and 15 age-matched male controls. We selected subjects who had a serum LDL cholesterol<160 mg/dL. The MDA-LDL levels were significantly higher in the CAD group than in the control group (P=0.01) even though there was no significant difference in the LDL cholesterol levels between the two groups. NMR analysis demonstrated that the MDA-LDL levels were positively correlated with large and intermediate very low-density lipoprotein triglyceride and LDL particle concentrations, and negatively correlated with LDL diameter and large high-density lipoprotein cholesterol. The MDA-LDL levels were negatively correlated with flow-mediated dilatation of the brachial artery.
CONCLUSIONS: The high concentrations of circulating MDA-LDL derived from the atherogenic lipoprotein profiles, which induce the exaggerated production of small dense LDL. The circulating MDA-LDL may impair endothelial function and play an important role in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15721020     DOI: 10.1016/j.atherosclerosis.2004.09.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

2.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

3.  Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.

Authors:  Outi Kummu; S Pauliina Turunen; Piotr Prus; Jaakko Lehtimäki; Marja Veneskoski; Chunguang Wang; Sohvi Hörkkö
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

4.  Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.

Authors:  Hiroyuki Oka; Satoshi Ikeda; Seiji Koga; Yoshiyuki Miyahara; Shigeru Kohno
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

5.  Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting.

Authors:  Tetsuro Miyazaki; Kazunori Shimada; Katsumi Miyauchi; Atsumi Kume; Kosei Tanimoto; Takashi Kiyanagi; Katsuhiko Sumiyoshi; Makoto Hiki; Hiroshi Mokuno; Shinya Okazaki; Hitoshi Sato; Takeshi Kurata; Hiroyuki Daida
Journal:  Lipids Health Dis       Date:  2010-10-25       Impact factor: 3.876

6.  The association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndrome.

Authors:  Kazuhiko Kotani; Toshiyuki Yamada; Nobuyuki Taniguchi
Journal:  Lipids Health Dis       Date:  2010-12-30       Impact factor: 3.876

7.  Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Sumiyo Yamashita; Satoru Tanaka; Genjiro Kimura
Journal:  Vasc Health Risk Manag       Date:  2011-07-19

8.  Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease.

Authors:  Alireza Yaghoubi; Morteza Ghojazadeh; Sakhavat Abolhasani; Hossein Alikhah; Fatemeh Khaki-Khatibi
Journal:  J Cardiovasc Thorac Res       Date:  2015

9.  Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes.

Authors:  Kazuya Fujihara; Hiroaki Suzuki; Akira Sato; Satoru Kodama; Yoriko Heianza; Kazumi Saito; Hitoshi Iwasaki; Kazuto Kobayashi; Shigeru Yatoh; Akimitsu Takahashi; Naoya Yahagi; Hiroaki Yagyu; Hirohito Sone; Hitoshi Shimano
Journal:  J Diabetes Res       Date:  2015-03-26       Impact factor: 4.011

Review 10.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.